Currently out of the existing stock ratings of Jeff Johnson, 200 are a BUY (73.26%), 72 are a HOLD (26.37%), 1 are a SELL (0.37%).

Jeff Johnson

Work Performance Price Targets & Ratings Chart

Analyst Jeff Johnson, currently employed at BAIRD, carries an average stock price target met ratio of 56.2% that have a potential upside of 19.23% achieved within 119 days.

Jeff Johnson’s has documented 583 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on DXCM, DexCom at 25-Sep-2025.

Wall Street Analyst Jeff Johnson

Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/22/2024. The price target of $28 was fulfilled within 1 day with a profit of $3 (12%) receiving and performance score of 120.

Average potential price target upside

of $45.63 (20.18%) on ALGN (ALIGN TECHNOLOGY).
of $36.46 (17.79%) on SYK (STRYKER).
of $34.98 (32.54%) on TDOC (TELADOC).

ALGN Align Technology DXCM DexCom HSIC Henry Schein INMD InMode Ltd NUVA NuVasive REPH Recro Pharma TDOC Teladoc TECH Bio-Techne Corp TNDM Tandem Diabetes Care XRAY Dentsply Sirona COO The Cooper Companies Common Stock NEO NeoGenomics PODD Insulet RGEN Repligen SYK Stryker BLFS BioLife Solutions BRKS Brooks Automation AZTA Azenta ZBH Zimmer Biomet Holdings ALC Alcon AG CDMO Avid Bioservices CDXS Codexis CYRX Cryoport ENOV Enovis Corp LGND Ligand Pharmaceuticals MXCT MaxCyte NVST Envista Holdings Corp OSUR OraSure Technologies PDCO Patterson Companies TKNO Alpha Teknova WST West Pharmaceutical Services CTLT Catalent MASS 908 Devices STE STERIS plc VAR Varian Medical Systems

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kevin Caliendo (UBS)